Exicure (XCUR) Total Liabilities (2016 - 2026)
Exicure (XCUR) reported Total Liabilities of $10.7 million for Q1 2026, up 14.62% on a YoY basis from $9.3 million in Q1 2025, and up 5.36% quarter-over-quarter from $10.1 million in Q4 2025.
Exicure (XCUR) Total Liabilities (2016 - 2026) Analysis & Trends
Exicure has reported Total Liabilities for 11 years, with the latest figure at $10.7 million in Q1 2026.
- For the quarter ending Q1 2026, Total Liabilities rose 14.62% year-over-year to $10.7 million; the trailing twelve-month figure through Mar 2026 stood at $10.7 million (up 14.62% YoY), and the FY2025 full-year result was $10.1 million, up 22.1% from the prior year.
- Total Liabilities for Q1 2026 stood at $10.7 million, up from $10.1 million in the prior quarter.
- The five-year high for Total Liabilities was $38.7 million in Q1 2022, with the low at $7.8 million in Q2 2023.
- Historically, Total Liabilities has averaged $13.7 million across 5 years, with a median of $9.1 million in 2024.
- Annual changes were most pronounced in 2022 — Total Liabilities slumped 84.33% — and 2025, when it increased 22.1%.
- Exicure's Total Liabilities stood at $8.4 million in 2022, then increased by 1.7% to $8.5 million in 2023, then fell by 3.1% to $8.3 million in 2024, then increased by 22.1% to $10.1 million in 2025, then rose by 5.36% to $10.7 million in 2026.
- The last three Total Liabilities figures came in at $10.7 million (Q1 2026), $10.1 million (Q4 2025), and $8.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 1.74 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 15.48 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 731.60 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 19.51 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 10.44 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 943,068.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 7.12 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 137.56 Mn |
| 10 | Exicure | 19.38 Mn | 16.77 Mn | - | 10.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.66 Mn |
| Dec 31, 2025 | 10.12 Mn |
| Sep 30, 2025 | 8.34 Mn |
| Jun 30, 2025 | 9.88 Mn |
| Mar 31, 2025 | 9.30 Mn |
| Dec 31, 2024 | 8.28 Mn |
| Sep 30, 2024 | 9.09 Mn |
| Jun 30, 2024 | 9.08 Mn |
| Mar 31, 2024 | 8.50 Mn |
| Dec 31, 2023 | 8.55 Mn |
| Sep 30, 2023 | 8.45 Mn |
| Jun 30, 2023 | 7.85 Mn |
| Mar 31, 2023 | 9.32 Mn |
| Dec 31, 2022 | 8.41 Mn |
| Sep 30, 2022 | 32.65 Mn |
| Jun 30, 2022 | 35.79 Mn |
| Mar 31, 2022 | 38.66 Mn |
| Dec 31, 2021 | 53.64 Mn |
| Sep 30, 2021 | 63.92 Mn |
| Jun 30, 2021 | 37.83 Mn |